0ME:FRA
Twist Bioscience Corp
€133.05
arrow_downward
-1.92%(-2.60) 1D
Sep 18, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0ME...
Open
€133.30
High
€133.30
Low
€133.05
Mkt. cap
11.07B
Avg. vol.
57.00
Volume
0.00
52-wk high
€134.70
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
Open
€133.30
High
€133.30
Low
€133.05
Mkt. cap
11.07B
Avg. vol.
57.00
Volume
0.00
52-wk high
€134.70
52-wk low
€21.69
Shares outstanding
222.04M
No. of employees
979
News stories
From web sources and news partners
The Motley Fool
·
8 hours ago
Why Twist Bioscience Stock Skyrocketed This Week
Timothy Sykes
·
12 hours ago
TWST Jumps As Twist Bioscience Lands Lilly AI TuneLab Deal
TradingView
·
19 hours ago
BWS Financial maintains Sell rating on Twist Bioscience, $45 price target
Trefis
·
1 day ago
Twist Bioscience Stock: 6 Straight Green Days, Up 24%
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp